Xtx Topco LTD Lineage Cell Therapeutics, Inc. Transaction History

Xtx Topco LTD

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 12, 2024	BUY	$0.89 - $1.47 $54,748 - $90,427	61,515 New	61,515 $61,000
Q4 2023 Feb 13, 2024	BUY	$0.91 - $1.35 $24,603 - $36,499	27,037 New	27,037 $29,000
Q3 2022 Nov 14, 2022	BUY	$1.13 - $1.77 $55,658 - $87,181	49,255 Added 209.13%	72,807 $82,000
Q2 2022 Aug 15, 2022	BUY	$1.12 - $1.61 $26,378 - $37,918	23,552 New	23,552 $37,000
Q1 2022 May 13, 2022	SELL	$1.21 - $2.48 $16,249 - $33,303	-13,429 Closed	0 $0
Q4 2021 Feb 11, 2022	BUY	$1.84 - $2.68 $24,709 - $35,989	13,429 New	13,429 $33,000

120

94.2M

63.8K

Ticker LCTX
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 169,755,008
Market Cap $91.7M
Description
Lineage Cell Therapeutics, Inc., a clinical-stage biotechnology company, develops novel cell therapies for the treatment of degenerative diseases in the United States and internationally. The company develops OpRegen, a retinal pigment epithelium cell replacement therapy, which is in Phase I/IIa clinical trial for the treatment of the dry age-re...

Get notified when there are updates to the investment portfolio of Xtx Topco LTD, based on Form 13F filings with the SEC.

Stay updated on Xtx Topco LTD with notifications on news.